Biotech

All Articles

Novo inks $600M NanoVation offer to analyze genetic medicines ex-liver

.Novo Nordisk is actually continuing its own push right into genetic medicines, accepting to pay Nan...

Innovent links cytokine to colorectal cancer feedbacks

.Innovent Biologics has made the instance that its own gate inhibitor-cytokine blend protein has a f...

Merck, Daiichi ADC reaches goal in period 3 lung cancer cells research

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina deepens AI focus along with collab to choose cancer targets

.Five months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism medicine smash hits in stage 3, endangers BioMarin

.Ascendis Pharma has become a possible threat to BioMarin's Voxzogo, reporting stage 3 development c...

Despite ph. 3 miss out on, Alkeus views course ahead of time for eye health condition resource

.Though Alkeus Pharmaceuticals' oral eye disease possession neglected to significantly lessen geogra...

Kairos goes public along with $6M IPO to finance tests of cancer medication

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to miss ...

Vaccine and also Keytruda combo successful in squamous tissue cancer

.Immune system gate inhibitors are actually the superheroes of cancer treatment. Medications like Br...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable management hirings, shootings as well...

Regeneron's Opdualag opponent presents 57% action cost

.Regeneron is back along with long-term follow-up for its LAG-3 inhibitor and also PD-1 prevention c...